Navigation Links
Codexis Names Sarret SVP, Corporate Development
Date:3/18/2009

REDWOOD CITY, Calif., March 18 /PRNewswire/ -- Codexis, Inc. today announced that Joseph Sarret, M.D., J.D., has been promoted to Senior Vice President, Corporate Development from his previous position as Vice President, Corporate Development. He continues to report to Alan Shaw, Ph.D., President and CEO.

Dr. Sarret was named Vice President, Corporate Development in 2007. He joined Codexis in 2005 as Corporate Counsel and Director, Business Development. Previously, he was an associate at Latham & Watkins LLP, where he provided legal services to life sciences companies. He also served as attending physician and later Acting Medical Director for the HIV Clinic at the University of California, San Francisco Medical Center. Dr. Sarret is a graduate of both the University of California, San Francisco School of Medicine and Stanford Law School. He received a bachelor's degree in human biology from Stanford, where he graduated Phi Beta Kappa.

"Under Joe Sarret's leadership, Codexis has established business partnerships with some of the world's premier companies in energy and pharmaceuticals," Dr. Shaw said. "He has played a significant role in the evolution of our biofuels collaboration with Shell, and in successful negotiations with leading life science companies now leveraging Codexis technology in their human therapeutics programs. His continuing contributions to building a strong business base for Codexis are important to maintaining our leadership in clean technology."

Codexis, Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes. Codexis technology is used in the energy industry to enable next generation, non-food biofuels and by global pharmaceutical companies for cost-effective manufacturing of human therapeutics. Future commercial applications include carbon management, water treatment and chemical manufacturing. For more information, visit www.codexis.com.

    Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or
    Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Irelands Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products
2. New Corporate Agreement with Legacy Hospital Partners, Inc. Names Broadlane Exclusive Provider of Supply Chain and Procurement Services
3. Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
4. ACP Medicine Names New Editor, Looks Toward Future of Medicine
5. VITAS Innovative Hospice Care(R) Names Karen Peterson Vice President and Chief Nursing Officer
6. NutraCea Names James C. Lintzenich As Interim CEO
7. Park Springs Names New Medical Director
8. Juvenile Diabetes Research Foundation Names Monye Connolly Corporate Chair for its Annual Walk to Cure Diabetes
9. SilverCensus.com Names Consumer Affairs Advocate, Healthcare Experts to Provide Free Educational Support for Seniors
10. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
11. National Electronic Attachment (NEA) Names EDI Health Group Top Clearinghouse for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, ... Over the past 20 years SFI has been recognized as the world’s leader in ... clients into the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, ...
(Date:1/19/2017)... ... 2017 , ... Each year, the Southeastern Society of Plastic ... of surgeons from over fifteen different countries come together to share and learn ... to breast reconstruction for breast cancer patients, teaching these surgical techniques which ...
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting ... global discussion about the benefits of fidgeting to relieve stress and anxiety. No ... Their Think Ink Pen had just completed a successful Kickstarter campaign raising $67,000 ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating ... untreated. , Certain Dri created this infographic to explain the seven types of ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... industry’s leading journal and most-read publication among specialty pharmacists and pharmacy professionals, ... through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and PUNE, India , January 18, ... Allied Market Research, titled, "Breast Imaging Technologies Market by Type: ... global breast imaging technologies market size was valued at $2,544 ... by 2022, growing at a CAGR of 8.4% from 2016 ... Europe together accounted for over three-fourths market ...
(Date:1/18/2017)... 2017   Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies to ... reported the Company,s operating results for 2016 and an ... the Company described in its recent 10-K filing with ... accomplishments. The Company,s contract laboratory completed its evaluation of ...
(Date:1/18/2017)... DAVOS , Suiza, 18 de enero de 2017 ... biofarmacéuticas líderes lanzaron Access Accelerated, una iniciativa global para ... comunicables (NCD) y atención en países de renta baja ... NCD han alcanzado un punto de crisis, particularmente en ... casi el 80 por ciento de las muertes relacionadas ...
Breaking Medicine Technology: